Skip to main content
Clinical application of deferasirox: practical patient management.
Pyrimethamine treatment does not ameliorate lymphoproliferation or autoimmune disease in MRL/lpr-/- mice or in patients with autoimmune lymphoproliferative syndrome.
Morbidity and mortality in chronically transfused subjects with thalassemia and sickle cell disease: A report from the multi-center study of iron overload.
Pulmonary hypertension in thalassemia: association with platelet activation and hypercoagulable state.
Fluorodeoxyglucose positron emission tomography (FDG-PET) for monitoring lymphadenopathy in the autoimmune lymphoproliferative syndrome (ALPS).
Comparison of organ dysfunction in transfused patients with SCD or beta thalassemia.
Central venous catheter complications in sickle cell disease.
Hydroxyurea and sodium phenylbutyrate therapy in thalassemia intermedia.
The perioperative complication rate of orthopedic surgery in sickle cell disease: report of the National Sickle Cell Surgery Study Group.
Role of positron emission tomography in determining the extent of CNS ischemia in patients with sickle cell disease.